Novartis

Novartis' pay-for-performance Entresto plan has its critics--Express Scripts' Miller among them
Fierce Pharma
Fri, 07/10/15 - 01:46 pm
Novartis
Entresto
Express Scripts
Novartis files leukemia drug Arzerra in the EU
BioPharma Dive
Thu, 07/9/15 - 07:42 pm
Novartis
Arzerra
Europe
Genmab
CLL
chronic lymphocytic leukemia
Novartis Heart Failure Drug Gains Speedy FDA Approval
Forbes
Tue, 07/7/15 - 07:14 pm
Novartis
heart failure
FDA
LCZ696
Entresto
Novartis tests performance pricing for much-anticipated Entresto launch
Fierce Pharma
Tue, 06/30/15 - 06:05 pm
Novartis
Entresto
drug launches
heart failure
Novartis (NVS) Stock Declines as U.S. Seeks $3.35 Billion Fine
TheStreet.com
Tue, 06/30/15 - 05:59 pm
Novartis
kickbacks
Exjade
Myfortic
Medicaid
Medicare
False Claims Act
Switzerland's Novartis buys US biotech firm Spinifex
Yahoo/AP
Mon, 06/29/15 - 10:47 am
Novartis
M&A
Spinifex
New data fuel hopes for broad use of Novartis psoriasis drug
Yahoo/Reuters
Mon, 06/29/15 - 10:46 am
Novartis
Cosentyx
psoriasis
How Novartis' CEO wants to tackle an ever-aging world
BioPharma Dive
Fri, 06/26/15 - 08:14 pm
Novartis
Joe Jimenez
aging
regenerative medicine
Novartis scores recommendation from EMA for myeloma drug Farydak
Fierce Pharma
Fri, 06/26/15 - 11:51 am
Novartis
Farydak
Multiple Myeloma
Europe
Novartis playing catch-up in cancer? Not us, says top oncology exec
Fierce Pharma Marketing
Wed, 06/24/15 - 08:35 am
Novartis
oncology
cancer
immuno-oncology
Pharma ad budgets to dip in 2016, but J&J, Pfizer, Roche and Novartis should still top $2B
Fierce Pharma Marketing
Mon, 06/22/15 - 12:52 pm
Pfizer
Roche
JNJ
Novartis
drug ads
It's Teva vs. Momenta/Sandoz for Copaxone patients, with Mylan's version MIA
Fierce Pharma Marketing
Mon, 06/22/15 - 10:52 am
Teva Pharmaceutical
Momenta
Sandoz
generics
Novartis
Copaxone
MS
multiple sclerosis
Novartis exec: Pharma culture can be stumbling block to creativity
Medical Marketing and Media
Sat, 06/20/15 - 09:47 am
creativity
innovation
Novartis
pharma industry
Biosimilar of Novartis' eye drug Lucentis launched in India
Fierce Pharma
Fri, 06/19/15 - 05:13 pm
Novartis
India
Lucentis
biosimilars
U.S. court nixes Teva's Copaxone patent--again
Fierce Pharma
Thu, 06/18/15 - 04:00 pm
Copaxone
patents
Teva Pharmaceuticals
generics
Momenta
Novartis
Sandoz
Novartis zeroes in on costs as blockbusters-to-be Cosentyx, Entresto rev up
Fierce Pharma
Thu, 06/18/15 - 11:10 am
Novartis
Cosentyx
Entresto
GSK
GSK deal keeps paying off for Novartis with more positive Arzerra data
Fierce Pharma
Fri, 06/12/15 - 10:53 pm
GSK
Novartis
Arzerra
chronic lymphocytic leukemia
This Key Amgen Drug Is Setting a Precedent
Investopedia
Tue, 06/9/15 - 09:55 am
Amgen
Neupogen
Zarxio
Novartis
biosimilars
Top Novartis brass backs results-based drug pricing
Fierce Pharma
Mon, 06/8/15 - 09:56 pm
Novartis
drug pricing
Digital campaigns that show pharma really can do it
Fierce Pharma Marketing
Mon, 06/8/15 - 10:44 am
digital marketing
Novartis
Bayer
Genentech
JNJ
Janssen

Pages